Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Helicon Therapeutics

Request full access

A privately held Company formed to discover therapeutics to treat disorders of cognition through an understanding of the genetic basis of long-term memory formation

Town of Huntington, United StatesFounded 1997Biotech & Life Sciences

About Helicon Therapeutics

Helicon Therapeutics was a privately held biopharmaceutical company that focused on the discovery and development of novel drugs for the treatment of cognitive disorders. The company's research was centered on understanding the genetic and molecular basis of memory formation, with the goal of identifying new therapeutic targets for conditions such as Alzheimer's disease, age-related memory loss, and other neurological disorders.

Helicon's business model was based on a research-intensive approach, leveraging its expertise in neuroscience and genetics to build a pipeline of potential drug candidates. The company was founded in 1997 as a spin-off from Cold Spring Harbor Laboratory, a renowned research institution. This academic affiliation provided Helicon with a strong scientific foundation and access to cutting-edge research.

The company operated in the highly competitive and regulated pharmaceutical industry, where the development of new drugs is a lengthy and expensive process. Helicon's strategy likely involved seeking partnerships with larger pharmaceutical companies to advance its drug candidates through clinical trials and commercialization. The company was ultimately acquired, which is a common exit strategy for successful biotechnology startups.

Source: Dealroom company data

At a glance

Status
Operational
Employees
7
Open positions
None listed
Dealroom signal
55.5/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Neurology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2C

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES FOther financing Sep 2009 $50M $200M Undisclosed —
SERIES EOther financing Oct 2006 $36M $144M Undisclosed —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Helicon Therapeutics website traffic

Latest recorded traffic for Helicon Therapeutics is 0 monthly website visits. Helicon Therapeutics's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Helicon Therapeutics in the Town of Huntington ecosystem

Live from Dealroom

The Helicon Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • Cold Spring Harbor Laboratory
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Town of Huntington HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Helicon Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Helicon Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.